No.4 Niloo St., Valiasr Ave., Tehran, Iran · +98 21 8865 8752 · genpeima.com
A single genetic test that tells your physician how your body is likely to process dozens of common medications — before the prescription is ever written.
Request Your TestPharmacogenomics (PGx) studies how inherited variation in the genes that metabolize, transport, and respond to drugs shapes each person's reaction to medication. The same drug, at the same dose, can be cleared quickly in one person and slowly in another — a difference that can mean the gap between a normal response, no benefit at all, or a serious side effect.
Because this genetic information doesn't change over time, testing it once gives a physician a durable reference point for choosing medications and doses — not just for a prescription being written today, but for many that may follow across a patient's care.
A single sample. A lifetime of pharmacogenomic reference data for your medical record.
29 genetic markers, organized into six functional categories relevant to everyday prescribing.
How quickly the body activates, breaks down, or clears a wide range of medications.
How efficiently drugs move into and out of cells, affecting blood concentration and side-effect risk.
Inherited clotting tendencies and sensitivity to blood thinners such as warfarin.
Tumor-pathway variants that inform eligibility for targeted cancer therapies.
Genetic factors linked to antidepressant response and opioid pain relief.
Rare but serious risks, including malignant hyperthermia susceptibility and anesthesia safety.
MolecularPGx results are cross-referenced against a wide library of medications across the therapeutic areas below.
…and more — ask our team for the complete medication list.
Start at the dose most likely to work, instead of the population average.
Flag genetic risk for serious side effects before a medication is prescribed.
Recommendations aligned with CPIC, FDA, and DPWG clinical guidelines.
Your DNA doesn't change — today's results remain relevant for future prescriptions.
A quick blood or buccal swab sample is collected at your clinic — no special preparation required.
DNA is analyzed by SNP microarray on the Infinium Global Screening Array, read on the Illumina iScan™ platform.
A structured, guideline-referenced report is delivered to your physician to support prescribing decisions.
Reduced SLCO1B1 transporter function can raise statin blood levels, increasing the risk of muscle-related side effects at standard doses — guiding a lower starting dose or an alternative statin.
Variation in CYP2D6 changes how the body activates or clears opioids such as codeine and tramadol, helping guide safer, more effective pain management.
Markers such as Factor V Leiden help assess inherited clotting risk ahead of surgery, pregnancy, or hormone-based therapy.
Illustrative examples of the type of insight pharmacogenomic testing can provide — not results from an actual patient.
Talk to our team about ordering MolecularPGx for your patients or practice.
Contact Us